Subtraction of baseline IFNγ spot counts (Fig. 8b; left panel) revealed that both mRIPO and LPS treatment generated tumor antigen-specific (SIINFEKL) IFNγ+ T cells (Fig. 8b; middle panel). Here, IFNG is linked to neoplasm.